NCT01128283已完成不适用
Temporal Behavior of Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Death
研究概览
简要总结
We will collect blood samples from patients with the diagnosis of sepsis and other ICU patients. We will describe the course of different mediator levels and organ injury markers and follow their progression throughout the course of the study.
详细描述
After informed consent is obtained 5 cc of blood is collected on the day of admission and on days 0, 1, 3, and 7 thereafter. Plasma is collected and frozen for the subsequent measurement of biomarkers.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Admission to the ICU
排除标准
- •No blood draws scheduled
- •Hemoglobin level < 6,5 gm/dl
结局指标
主要结局
Death
时间窗: 30 days
Survival at 30 days
次要结局
未报告次要终点
研究者
Gary Kinasewitz
Principal Investigator
University of Oklahoma
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical InfectionsCritical IllnessSars-CoV2Viral InfectionCoagulation Disorder, BloodCovid19Disseminated Intravascular CoagulationNCT04356144Medical University of Vienna58
Unknown
不适用
Biological Collection and Registry of Patients Who Will Have a TAVR (Transcatheter Aortic Valve Replacement) InterventionTranscatheter Aortic Valve ReplacementNCT02812953Action, France600
已完成
不适用
Markers of Inflammation and Metabolism in the ERAcute InfectionSepsisNCT03494790University of Helsinki955
已完成
不适用
Coagulation Factors, Cytokines and Tissue Injury Markers in SepsisSepsisNCT01012115University of Oklahoma500
已完成
不适用
Blood Volume Assessment in COVID-19 and Bacterial SepsisCovid19Bacterial SepsisBacterial InfectionsAcute Respiratory Distress SyndromeNCT04517695NYU Langone Health39